Pfizer

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Doctors Without Borders chastises Pfizer for refusing to lower vaccine price

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: To avoid scandal, Novartis CEO advises companies not to hire rulebreakers

Pharmalot Ed Silverman

Pfizer won’t split into two companies, so what’s next?

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Pfizer decides not to split into two companies

Pharmalot Ed Silverman

FDA panel votes to remove serious warning from Pfizer’s smoking cessation pill

Pharmalot Ed Silverman

FDA reviewers question Pfizer study about safety of its Chantix smoking cessation pill

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Pfizer CEO says Clinton drug pricing plan is ‘very negative’

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Are concerns about spending on orphan drugs overblown?

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Docs disciplined for misconduct still paid by pharma to be speakers, advisers

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: India wants you to know its drugs are safe and effective

Business Associated Press

Pfizer buying Medivation in deal valued at about $14 billion

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Pfizer pays $14 billion for Medivation and its prostate cancer drug

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: North Korea’s Neo-Viagra has the same ingredient as the real thing

Pharmalot Ed Silverman

Pfizer closes plant in India after several regulators find problems

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Bristol-Myers cancer drug misses main goal in late-stage study